• Press Release

Sharon Grimster (ReNeuron) and Sarah Goulding (Knowledge Transfer Network) to be recognised at bioProcessUK conference

Sharon Grimster of ReNeuron and Dr Sarah Goulding of the Knowledge Transfer Network (KTN) will be awarded the prestigious Peter Dunnill award and Richard Wilson impact award respectively, at the UK BioIndustry Association’s (BIA) 16th bioProcessUK conference in Liverpool later this month.

BIA launches biotech manifesto

The United Kingdom (UK) will have a general election on Thursday, 12 December. The UK BioIndustry Association (BIA) has today launched a biotech manifesto with its recommendations on how political parties can support the innovative UK life sciences sector.

BIA responds to the Smith - Reid Review on international research partnerships

Steve Bates OBE, Chief Executive of the BioIndustry Association (BIA) said: “Thanks to new advances in science and innovation, we are at the cusp of a new industrial revolution, however Brexit is causing much uncertainty for UK SMEs. I welcome the publication of this important review and it is good to see the Science Minister recognising the valuable contribution the life sciences sector makes in discovering new cures for life-threatening diseases.

BIA announces new Chair and appointments to the BIA Board

Following the BIA AGM at the UK Bioscience Forum, the Association has announced the new Chair and members who have been elected to its Board of Directors.

BIA welcomes news of deal between Vertex and NHS England

Steve Bates OBE, CEO of the BIA said: “We welcome today’s announcement that NHS England and Vertex have been able to reach a deal and that this drug will soon be available to patients and their families. This is one of a number of deals that the NHS has reached with industry to bring life-saving treatments to patients, showing that the UK’s health service is committed to innovation and being at the cutting edge of medical products.

GE Healthcare opens lab for life science start-ups at Alderley Park, United Kingdom

● Lab will support acceleration of biotechnology, health and life sciences research in the UK ● Companies to gain access to fully-equipped lab with the latest GE Healthcare Life Sciences technologies

Refilling the Biomedical Catalyst must now be an urgent government priority

The UK BioIndustry Association (BIA) is calling on the Government to refill the Biomedical Catalyst as an urgent priority, as analysis from IPSOS Mori showed that the R&D funding programme generates £4.72 in public and business value for every £1 invested by the Government.

BIA reaction to Queen’s speech

​​​​​​​Steve Bates OBE, CEO of the BIA said: “It’s great to hear the Government recognises the enormous contribution of the UK life sciences sector to the wider UK economy, which was highlighted at numerous points in today’s Queen’s speech.

BIA exchanges member directories with Japanese leader in regenerative medicine

The UK Bioindustry Association (BIA) has exchanged member directories with The Forum for Innovative Regenerative Medicine (FIRM).

BIA respond to written ministerial statement on continuity of supply in a no-deal Brexit

Steve Bates OBE, Chief Executive of the BIA said: “I ask all companies that are seeking to use the Government procured supply routes to import and export medicines in the event of a no-deal to register their interest immediately. This is best done by replying to the communication from the Department of Health yesterday. This is a key step to enable companies to book and purchase government procured ferry space -as details of it emerge- in the weeks ahead.